June 2006
Worldwide Biotech;Jun2006, Vol. 18 Issue 6, p5
Trade Publication
Focuses on the services agreement established between Strategic Diagnostics Inc. (SDI) and Berlex Inc. Move by Berlex to extend its services agreement to include newly commercialized Genomic Antibodies offering of SDI; Plan by SDI to provide polyclonal and monoclonal Genomic Antibodiesâ„¢ to Berlex; Information about Genomic Antibodiesâ„¢.


Related Articles

  • Magic bullets hit the target. Gura, Trisha // Nature;6/6/2002, Vol. 417 Issue 6889, p584 

    Explores pharmaceutical firms' efforts to develop monoclonal antibodies for used as drugs in the U.S. Clinical trials of monoclonal antibodies; Monoclonal therapies approved by the Food and Drug Administration; Effectiveness of monoclonals against cancer.

  • Feeding the pipeline with monoclonal antibodies. Papanikolaw, Jim // Chemical Market Reporter;11/23/98, Vol. 254 Issue 21, pFR15 

    Focuses on the market potential for monoclonal antibodies in the pharmaceuticals market. Mabs as the industry segment with the most number of new biotechnology medicines being developed; Overview on the efforts of various industry players in catching up with the research trend for such industry...

  • MAGIC BULLETS WITH A HEFTY PRICE TAG. Shaughnessy, Allen // BMJ: British Medical Journal;12/15/2012, Vol. 345 Issue 7887, p18 

    The article discusses the sale and use of monoclonal antibodies such as Alemtuzumab and Natalizumab and their marketing by drug manufacturing companies. It explains the use of monoclonal antibodies for treatment and the evidence supporting it. It states the reason for expensiveness of monoclonal...

  • Berlex Labs Contacts Shops On $20-25 Mil. Drug Account.  // Adweek Eastern Edition;12/15/2003, Vol. 44 Issue 49, p4 

    The U.S. affiliate of German drug giant Schering AG, has contacted agencies about its estimated $20-25 million account, sources said. New Jersey based Berlex Inc. markets women's contraceptives and drugs that treat cancer, skin disorders and other debilitating diseases. McCann-Erickson in New...

  • IPT, Meristem and Croptech Race Toward the MAb Market. Jarvis, Lisa // Chemical Market Reporter;9/24/2001, Vol. 260 Issue 11, p10 

    Reports on the research conducted by pharmaceutical companies on the application of transgenic corn in the production of human monoclonal antibodies. Problems faced in the development of monoclonal antibodies; Significance of the success of biotechnology-based drugs; Competition between...

  • U.S. Faces Protein Deficiency. Creswell, Julie // Fortune;5/28/2001, Vol. 143 Issue 11, p30 

    Focuses on the development of protein drugs which include monoclonal antibodies called mabs. How the drugs are based on human proteins and have fewer side effects that traditional therapies; Difficulty of making the drugs, which are created chiefly from the cells of Chinese hamster ovaries or...

  • Greg Winter.  // Nature Biotechnology;Mar2011, Vol. 29 Issue 3, p190 

    An interview with Cambridge Antibody Technology cofounder Greg Winter is presented. When asked why it took so long for the pharmaceutical industry to recognize the value of monoclonal antibodies (mAbs), he mentions how the large pharmaceutical firms did not believe in mAbs. Winter adds that the...

  • Biomanufacturing capacity: Current and future requirements. Sinclair, Andrew // Journal of Commercial Biotechnology;Summer2001, Vol. 8 Issue 1, p43 

    In recent years the perception has arisen that biopharmaceuticals manufacturing capacity has gone from excess to shortage. What is the cause of this change and why were the shortfalls not addressed in time? This paper looks at how the structure of the industry has influenced the current...

  • Strategies for improving communication between scientists and the public. Clarke, Belinda R. // Journal of Commercial Biotechnology;Summer2001, Vol. 8 Issue 1, p51 

    It is believed that a scientifically literate society benefits the national economy by improving the workforce and raising consumer awareness by helping people appreciate and support scientific advancement. Traditionally, communication between scientists and the public has been viewed as...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics